Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,909-1,920 of 4,306
Drug study icon
CompletedNCT01678755

ABT-126 for schizophrenia

This study is completed in the United States. It is testing ABT-126 for schizophrenia.

Multiple locations, including Chino
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 20 Years to 55 Years
Countries
United States
Sponsor
AbbVie (prior sponsor, Abbott)
Condition
Schizophrenia
Drug study icon
CompletedNCT02873208

Safety study of ALKS 3831 in schizophrenia

This study is completed in the United States. It is testing ALKS 3831 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT02476877

A Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse

This summary needs review. Please check the official study record and contact the research team for details.

In Brooklyn
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Bipolarity, ...ObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
Advanced Clinical Laboratory Solutions, Inc.
Condition
Schizophrenia, Bipolarity, ...
Drug study icon
CompletedNCT00455715

A Single-Dose study of Sildenafil in Schizophrenia

This study is completed in the United States. It is testing Placebo-Controlled Single-Dose Trial of Sildenafil for schizophrenia.

In Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00351936

A Cross-Over study of Aripiprazole

This study is completed in the United States. It focuses on Schizophrenia.

In Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
North Suffolk Mental Health Association
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.